Diabetes type 2

All type of patients:  43 trials  - Foley - Lukashevich - Iwamoto - Kikuchi - Matthews - Ahren - Bosi - Ferrannini - Filozof - Foley - GALIANT (Blonde) - Goodman - Kikuchi - Rosenstock - Schweizer - Bolli - Fonseca - Garber - Goke - Pan - Rosenstock - Scherbaum [2] - Bosi - Dejager [1] - Fonseca - Garber - Pi-Sunyer - Rosenstock* (vilda vs rosi) - Rosenstock** (vilda + pio vs pio) - Rosenstock** (vilda vs pio) - Schweizer - Mimori - Pratley - Ristic - Ahren - CLAF237A 23104 - NCT00101673 - NCT00351832 - NCT00368134 - NCT00396071 - NCT00494884 (Wollmer) - NCT00728351 - NCT00822211

All types of patients:  43 trials  - Foley - Lukashevich - Iwamoto - Kikuchi - Matthews - Ahren - Bosi - Ferrannini - Filozof - Foley - GALIANT (Blonde) - Goodman - Kikuchi - Rosenstock - Schweizer - Bolli - Fonseca - Garber - Goke - Pan - Rosenstock - Scherbaum [2] - Bosi - Dejager [1] - Fonseca - Garber - Pi-Sunyer - Rosenstock* (vilda vs rosi) - Rosenstock** (vilda + pio vs pio) - Rosenstock** (vilda vs pio) - Schweizer - Mimori - Pratley - Ristic - Ahren - CLAF237A 23104 - NCT00101673 - NCT00351832 - NCT00368134 - NCT00396071 - NCT00494884 (Wollmer) - NCT00728351 - NCT00822211

Patients inadequately controlled on metformin:  5 trials  - Ferrannini - Goodman - Bolli - Bosi - Ahren

Patients inadequately controlled on monotherapy :  8 trials  - Ferrannini - Goodman - Bolli - Bosi - Fonseca - Garber - Rosenstock** (vilda + pio vs pio) - Ahren

Patients inadequately controlled on TZD:  2 trials  - Garber - Rosenstock** (vilda + pio vs pio)

Patients inadequately controlled with insulin:  1 trials  - Fonseca